XML 20 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
EPT - Condensed Consolidated Statements of Equity for the three months ended March 31, 2024 and 2023 (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Distributions in excess of accumulated earnings
Accumulated other comprehensive income, net
Noncontrolling interest
Balance at period beginning (in shares) at Dec. 31, 2022   64,605        
Balance at period beginning at Dec. 31, 2022 $ 5,895,116 $ 6 $ 6,750,076 $ (1,080,176) $ 46,466 $ 178,744
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 161,594     153,532   8,062
Change in fair value of derivatives and amortization of swap settlements (10,294)       (9,944) (350)
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   2        
Stock option and restricted stock plans, net 0          
Sale of common stock, net (72)   (72)      
Equity based compensation costs 5,664   5,472     192
Retirement of common stock, net (in shares)   (437)        
Retirement of common stock, net (95,657)   (95,657)      
Changes in the redemption value of redeemable noncontrolling interest (3,058)   (2,927)     (131)
Distributions to noncontrolling interest (7,977)         (7,977)
Redemptions of noncontrolling interest (in shares)   12        
Redemptions of noncontrolling interest (173)   291     (464)
Common stock dividends (148,286)     (148,286)    
Balance at period end (in shares) at Mar. 31, 2023   64,182        
Balance at period end at Mar. 31, 2023 5,796,857 $ 6 6,657,183 (1,074,930) 36,522 178,076
Balance at period beginning (in shares) at Dec. 31, 2023   64,203        
Balance at period beginning at Dec. 31, 2023 5,593,978 $ 6 6,656,720 (1,267,536) 33,556 171,232
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 285,140     272,731   12,409
Change in fair value of derivatives and amortization of swap settlements 7,995       7,723 272
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   6        
Stock option and restricted stock plans, net 962   962      
Sale of common stock, net (8)   (8)      
Equity based compensation costs 1,695   1,637     58
Changes in the redemption value of redeemable noncontrolling interest 13   (180)     193
Distributions to noncontrolling interest (8,412)         (8,412)
Redemptions of noncontrolling interest (279)   (249)     (30)
Common stock dividends (157,331)     (157,331)    
Balance at period end (in shares) at Mar. 31, 2024   64,209        
Balance at period end at Mar. 31, 2024 $ 5,723,753 $ 6 $ 6,658,882 $ (1,152,136) $ 41,279 $ 175,722